Status:
TERMINATED
Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients
Lead Sponsor:
Pfizer
Conditions:
Hypertension
Eligibility:
All Genders
18-65 years
Brief Summary
The purpose of this study is to determine the safety, tolerability and efficacy of Amlodipine and Olmesartan medoxomil among Hypertensive Filipino patients.
Eligibility Criteria
Inclusion
- Filipino hypertensive subjects ages 18-65 years old whether naive or currently taking any other anti-hypertensive or those on monotherapy using CCBs or ARBs whom they want to shift on a fixed dose combination drug
Exclusion
- Patients with contraindications to any of the component of the fixed drug (amlodipine or olmesartan medoxomil) or with malignant or secondary hypertension
Key Trial Info
Start Date :
June 9 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 4 2014
Estimated Enrollment :
615 Patients enrolled
Trial Details
Trial ID
NCT01200407
Start Date
June 9 2010
End Date
January 4 2014
Last Update
August 17 2021
Active Locations (52)
Enter a location and click search to find clinical trials sorted by distance.
1
Lorma Medical Center
San Fernando City, LA Union, Philippines, 2500
2
Holy Child Hospital
Taclobo, Dumaguete City, Negros Oriental, Philippines
3
Private Clinic
Albay, Philippines
4
Private Clinic
Angono, Philippines